Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Sheahan

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|February 3, 2021
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in miceDavid R Martinez, Alexandra Schaefer, Sarah R Leist, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection <i>in vivo</i>Alexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Cell Reports|July 21, 2021
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in miceDavid R Martinez, Alexandra Schäfer, Sarah R Leist, et al.
Mbio|August 10, 2021
Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung InjuryAmy C Sims, Hugh D Mitchell, Lisa E Gralinski, et al.
Communications Biology|December 31, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Bioorganic & Medicinal Chemistry|September 12, 2025
Novel tricycle expanded purine nucleosides with pan-viral activityCéline Martin-Ghoteimi, Kyle A Davis, Rayane Ghoteimi, et al.
Journal of Virology|October 4, 2019
Small-Molecule Antiviral β-d-<i>N</i><sup>4</sup>-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to ResistanceMaria L Agostini, Andrea J Pruijssers, James D Chappell, et al.
Mbio|March 8, 2018
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading ExoribonucleaseMaria L Agostini, Erica L Andres, Amy C Sims, et al.
Science Translational Medicine|April 28, 2022
Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanismsLaura J Stevens, Andrea J Pruijssers, Hery W Lee, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|February 3, 2021
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in miceDavid R Martinez, Alexandra Schaefer, Sarah R Leist, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection <i>in vivo</i>Alexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Cell Reports|July 21, 2021
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in miceDavid R Martinez, Alexandra Schäfer, Sarah R Leist, et al.
Mbio|August 10, 2021
Unfolded Protein Response Inhibition Reduces Middle East Respiratory Syndrome Coronavirus-Induced Acute Lung InjuryAmy C Sims, Hugh D Mitchell, Lisa E Gralinski, et al.
Communications Biology|December 31, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Bioorganic & Medicinal Chemistry|September 12, 2025
Novel tricycle expanded purine nucleosides with pan-viral activityCéline Martin-Ghoteimi, Kyle A Davis, Rayane Ghoteimi, et al.
Journal of Virology|October 4, 2019
Small-Molecule Antiviral β-d-<i>N</i><sup>4</sup>-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to ResistanceMaria L Agostini, Andrea J Pruijssers, James D Chappell, et al.
Mbio|March 8, 2018
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading ExoribonucleaseMaria L Agostini, Erica L Andres, Amy C Sims, et al.
Science Translational Medicine|April 28, 2022
Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanismsLaura J Stevens, Andrea J Pruijssers, Hery W Lee, et al.
Pageof 9